CSF1 and neoplasm: For instance, interventions aimed at inhibiting M-CSF or their receptor, colony-stimulating factor 1 receptor (CSF-1R), hold the potential to modulate the tumor microenvironment, thereby impeding tumor progression and offering improved survival prospects for patients.